1
|
Abstract
Transcription Factor (TF) condensates are a heterogenous mix of RNA, DNA, and multiple co-factor proteins capable of modulating the transcriptional response of the cell. The dynamic nature and the spatial location of TF-condensates in the 3D nuclear space is believed to provide a fast response, which is on the same pace as the signaling cascade and yet ever-so-specific in the crowded environment of the nucleus. However, the current understanding of how TF-condensates can achieve these feet so quickly and efficiently is still unclear. In this review, we draw parallels with other protein condensates and share our speculations on how the nucleus uses these TF-condensates to achieve high transcriptional specificity and fidelity. We discuss the various constituents of TF-condensates, their properties, and the known and unknown functions of TF-condensates with a particular focus on steroid signaling-induced transcriptional programs.
Collapse
Affiliation(s)
- Rajat Mann
- National Centre for Biological Sciences, TIFR, Bangalore, India
| | - Dimple Notani
- National Centre for Biological Sciences, TIFR, Bangalore, India
| |
Collapse
|
2
|
Walker M, Carpino M, Lightfoot D, Rossi E, Tang M, Mann R, Saarela O, Cusimano MD. The effect of recreational cannabis legalization and commercialization on substance use, mental health, and injury: a systematic review. Public Health 2023; 221:87-96. [PMID: 37429043 DOI: 10.1016/j.puhe.2023.06.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 05/29/2023] [Accepted: 06/08/2023] [Indexed: 07/12/2023]
Abstract
OBJECTIVE To determine the effect of recreational cannabis legalization (RCL) and/or recreational cannabis commercialization (RCC) on emergency department (ED) visits, hospitalizations, and deaths due to substance use, injury, and mental health among those aged 11 years and older. METHODS A systematic review of six electronic databases up to February 1, 2023. Original, peer-reviewed articles with interrupted time series or before and after designs were included. Four independent reviewers screened articles and assessed risk of bias. Outcomes with 'critical' risk of bias were excluded. Protocol registered on PROSPERO (# CRD42021265183). RESULTS After screening and risk of bias assessment, 29 studies were included which examined ED visits or hospitalizations for cannabis use or alcohol (N = 10), opioid mortality (N = 3), motor vehicle fatalities or injury (N = 11), and intentional injury/mental health (N = 5). Rates or number of cannabis-related hospitalizations increased after RCL in Canada and the USA. Immediate increases in rates of cannabis-related ED visits were found after both RCL and RCC in Canada. Rates of traffic fatalities increased after RCL and RCC in certain jurisdictions in the USA. CONCLUSIONS RCL was associated with increased rates of cannabis-related hospitalizations. RCL and/or RCC was associated with increased rates of cannabis-related ED visits, consistently shown across sex and age groups. The effect on fatal motor vehicle incidents was mixed, with observed increases found after RCL and/or RCC. The effect of RCL or RCC on opioids, alcohol, intentional injury, and mental health is not clear. These results inform population health initiatives and international jurisdictions considering RCL implementation.
Collapse
Affiliation(s)
- M Walker
- Injury Prevention Research Office, Division of Neurosurgery, St. Michael's Hospital, Toronto, Ontario, Canada
| | - M Carpino
- Injury Prevention Research Office, Division of Neurosurgery, St. Michael's Hospital, Toronto, Ontario, Canada
| | - D Lightfoot
- Health Sciences Library, St. Michael's Hospital, Toronto, Ontario, Canada
| | - E Rossi
- Injury Prevention Research Office, Division of Neurosurgery, St. Michael's Hospital, Toronto, Ontario, Canada
| | - M Tang
- Injury Prevention Research Office, Division of Neurosurgery, St. Michael's Hospital, Toronto, Ontario, Canada
| | - R Mann
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - O Saarela
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - M D Cusimano
- Injury Prevention Research Office, Division of Neurosurgery, St. Michael's Hospital, Toronto, Ontario, Canada.
| |
Collapse
|
3
|
Schmitz R, Sondermeijer C, van der Noort V, Engelhardt E, Gerritsma M, Verschuur E, van Oirsouw M, Bleiker E, Bijker N, Mann R, van Duijnhoven F, Wesseling J. The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01355-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
4
|
Sanderink W, Mann R. MINIVAB trial: Minimally invasive breast cancer excision using vacuum assisted biopsy under ultrasound guidance. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)01383-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
5
|
Conlon R, Corey D, Wilson M, Mansbach S, Rosenjack J, Duesler L, Wilson A, Davis S, Michicich M, Schneider M, Traylor Z, Jiang W, LePage D, Mann R, Kelley T, Hodges C. 640 The cystic fibrosis mouse model resource center. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)01330-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
6
|
Nederlof I, Isaeva O, Bakker N, de Graaf M, Salgado R, Klioueva N, Van De Vijver K, van Duijnhoven F, Kalashnikova E, Willingham S, Luykx S, Loo C, Kerver E, Sonke G, Blank C, Mann R, Linn S, Lambrechts D, Horlings H, Kok M. LBA13 Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.08.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
7
|
Wenlock RD, Tausan M, Mann R, Garr W, Preston R, Arnold A, Hoban J, Webb L, Quick C, Beckett A, Loveson K, Glaysher S, Elliott S, Malone C, Cogger B, Easton L, Robson SC, Hassan-Ibrahim MO, Sargent C. Nosocomial or not? A combined epidemiological and genomic investigation to understand hospital-acquired COVID-19 infection on an elderly care ward. Infect Prev Pract 2021; 3:100165. [PMID: 34485893 PMCID: PMC8397489 DOI: 10.1016/j.infpip.2021.100165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2021] [Accepted: 07/23/2021] [Indexed: 10/27/2022] Open
Abstract
Background COVID-19 has the potential to cause outbreaks in hospitals. Given the comorbid and elderly cohort of patients hospitalized, hospital-acquired COVID-19 infection is often fatal. Pathogen genome sequencing is becoming increasingly important in infection prevention and control (IPC). Aim To inform the understanding of in-hospital SARS-CoV-2 transmission in order to improve IPC practices and to inform the future development of virological testing for IPC. Methods Patients detected COVID-19 positive by polymerase chain reaction on Ward A in April and May 2020 were included with contact tracing to identify other potential cases. Genome sequencing was undertaken for a subgroup of cases. Epidemiological, genomic, and cluster analyses were performed to describe the epidemiology and to identify factors contributing to the outbreak. Findings Fourteen cases were identified on Ward A. Contact tracing identified 16 further patient cases; in addition, eight healthcare workers (HCWs) were identified as being COVID-19 positive through a round of asymptomatic testing. Genome sequencing of 16 of these cases identified viral genomes differing by two single nucleotide polymorphisms or fewer, with further cluster analysis identifying two groups of infection (a five-person group and a six-person group). Conclusion Despite the temporal relationship of cases, genome sequencing identified that not all cases shared transmission events. However, 11 samples were found to be closely related and these likely represented in-hospital transmission. This included three HCWs, thereby confirming transmission between patients and HCWs.
Collapse
Affiliation(s)
- R D Wenlock
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - M Tausan
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - R Mann
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - W Garr
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - R Preston
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - A Arnold
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - J Hoban
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - L Webb
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - C Quick
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - A Beckett
- Centre for Enzyme Innovation, University of Portsmouth, Portsmouth, UK
| | - K Loveson
- School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK
| | - S Glaysher
- Portsmouth Hospitals University NHS Trust, Portsmouth, UK
| | - S Elliott
- Portsmouth Hospitals University NHS Trust, Portsmouth, UK
| | - C Malone
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - B Cogger
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - L Easton
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | | | - S C Robson
- Centre for Enzyme Innovation, University of Portsmouth, Portsmouth, UK.,School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK
| | | | - C Sargent
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| |
Collapse
|
8
|
Evans D, Bolden R, Jarvis C, Mann R, Patterson M, Thompson E. How do you develop systems leadership in public health? Insights from a scoping study. Public Health 2021; 196:24-28. [PMID: 34134012 DOI: 10.1016/j.puhe.2021.04.033] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Revised: 04/13/2021] [Accepted: 04/30/2021] [Indexed: 10/21/2022]
Abstract
OBJECTIVES Systems leadership is widely acknowledged to be needed to address the many 'wicked issues' challenging public health systems. However, there is a lack of evidence on how to develop public health professionals into effective systems leaders. This study scoped the possibilities for developing the systems leadership capacity of public health specialists in England. STUDY DESIGN This was a mixed-methods qualitative scoping study design. METHODS The study involved three stages. In the first, a rapid literature review mapped key documents in three relevant areas: systems leadership theory and practice, the changing context of public health in the UK, and training and development for UK public health professionals. In the second, 29 stakeholders were consulted to understand the context and needs for systems leadership development in public health. A third phase involved stakeholders codesigning a potential development framework for the project commissioners. RESULTS Four main themes were identified: the nature and purpose of systems leadership; development needs and opportunities for public health specialists; the enabling environment; and wider contextual factors impacting public health. CONCLUSIONS Key principles of, and a framework for, a systems leadership development approach are identified, which could be applied to any public health system.
Collapse
Affiliation(s)
- D Evans
- Department of Health and Social Sciences, University of the West of England, Bristol, BS16 1QY, UK.
| | - R Bolden
- Faculty of Business and Law, University of the West of England, Bristol, BS16 1QY, UK
| | - C Jarvis
- Faculty of Business and Law, University of the West of England, Bristol, BS16 1QY, UK
| | - R Mann
- Independent Leadership and Organisational Development Consultant in Health, UK
| | - M Patterson
- Independent Leadership and Organisational Development Consultant in Health, UK
| | - E Thompson
- Independent Leadership and Organisational Development Consultant in Health, UK
| |
Collapse
|
9
|
Tilanus-Linthorst M, Geuzinge A, Obdeijn I, Rutgers E, Mann R, Saadatmand S, de Roy van Zuidewijn D, Oosterwijk J, Tollenaar R, Ausems M, van 't Riet M, Margrethe S, Hooning M, Wesseling J, Kristine K, Luiten E, Verhoef C, Heijnsdijk E, de Koning H. FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe. Eur J Surg Oncol 2021. [DOI: 10.1016/j.ejso.2020.11.196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
10
|
Walavalkar K, Saravanan B, Singh AK, Jayani RS, Nair A, Farooq U, Islam Z, Soota D, Mann R, Shivaprasad PV, Freedman ML, Sabarinathan R, Haiman CA, Notani D. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer. Nat Commun 2020; 11:3598. [PMID: 32680982 PMCID: PMC7368061 DOI: 10.1038/s41467-020-17325-y] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Accepted: 06/24/2020] [Indexed: 11/18/2022] Open
Abstract
Genetic variation at the 8q24 locus is linked with the greater susceptibility to prostate cancer in men of African ancestry. One such African ancestry specific rare variant, rs72725854 (A>G/T) (~6% allele frequency) has been associated with a ~2-fold increase in prostate cancer risk. However, the functional relevance of this variant is unknown. Here we show that the variant rs72725854 is present in a prostate cancer-specific enhancer at 8q24 locus. Chromatin-conformation capture and dCas9 mediated enhancer blocking establish a direct regulatory link between this enhancer and lncRNAs PCAT1, PRNCR1 and PVT1. The risk allele (‘T’) is associated with higher expression of PCAT1, PVT1 and c-myc in prostate tumors. Further, enhancer with the risk allele gains response to androgen stimulation by recruiting the transcription factor SPDEF whereas, non-risk alleles remain non-responsive. Elevated expression of these lncRNAs and c-myc in risk allele carriers may explain their greater susceptibility to prostate cancer. Genetic variants on chromosome 8q24 are associated with prostate cancer risk in men of African ancestry. Here the authors show that one of these variants, rs72725854 alters the enhancer activity in its region, which upon androgen stimulation, activates multiple oncogenic lncRNAs and c-myc.
Collapse
Affiliation(s)
- Kaivalya Walavalkar
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India
| | - Bharath Saravanan
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India.,Sastra Deemed University, Thanjavur, Tamil Nadu, 613401, India
| | - Anurag Kumar Singh
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India
| | - Ranveer Singh Jayani
- Howard Hughes Medical Institute, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92037, USA
| | - Ashwin Nair
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India.,Sastra Deemed University, Thanjavur, Tamil Nadu, 613401, India
| | - Umer Farooq
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India.,Trans-Disciplinary University, IVRI road, Bangalore, Tamil Nadu, 560064, Karnataka, India
| | - Zubairul Islam
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India.,Sastra Deemed University, Thanjavur, Tamil Nadu, 613401, India
| | - Deepanshu Soota
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India
| | - Rajat Mann
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India
| | - Padubidri V Shivaprasad
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India
| | - Matthew L Freedman
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.,The Eli and Edythe L. Broad Institute, Cambridge, MA, 02142, USA.,Centre for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, 02215, USA
| | - Radhakrishnan Sabarinathan
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India
| | - Christopher A Haiman
- Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90007, USA
| | - Dimple Notani
- Genetics and Development, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, Karnataka, 560065, India.
| |
Collapse
|
11
|
Saravanan B, Soota D, Islam Z, Majumdar S, Mann R, Meel S, Farooq U, Walavalkar K, Gayen S, Singh AK, Hannenhalli S, Notani D. Ligand dependent gene regulation by transient ERα clustered enhancers. PLoS Genet 2020; 16:e1008516. [PMID: 31905229 PMCID: PMC6975561 DOI: 10.1371/journal.pgen.1008516] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Revised: 01/22/2020] [Accepted: 11/12/2019] [Indexed: 12/31/2022] Open
Abstract
Unliganded Estrogen receptor alpha (ERα) has been implicated in ligand-dependent gene regulation. Upon ligand exposure, ERα binds to several EREs relatively proximal to the pre-marked, unliganded ERα-bound sites and affects transient but robust gene expression. However, the underlying mechanisms are not fully understood. Here we demonstrate that upon ligand stimulation, persistent sites interact extensively, via chromatin looping, with the proximal transiently ERα-bound sites, forming Ligand Dependent ERα Enhancer Cluster in 3D (LDEC). The E2-target genes are regulated by these clustered enhancers but not by the H3K27Ac super-enhancers. Further, CRISPR-based deletion of TFF1 persistent site disrupts the formation of its LDEC resulting in the loss of E2-dependent expression of TFF1 and its neighboring genes within the same TAD. The LDEC overlap with nuclear ERα condensates that coalesce in a ligand and persistent site dependent manner. Furthermore, formation of clustered enhancers, as well as condensates, coincide with the active phase of signaling and their later disappearance results in the loss of gene expression even though persistent sites remain bound by ERα. Our results establish, at TFF1 and NRIP1 locus, a direct link between ERα condensates, ERα enhancer clusters, and transient, but robust, gene expression in a ligand-dependent fashion.
Collapse
Affiliation(s)
- Bharath Saravanan
- Cellular Organization and Signalling, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
- School of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, India
| | - Deepanshu Soota
- Cellular Organization and Signalling, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
| | - Zubairul Islam
- Cellular Organization and Signalling, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
| | - Sudeshna Majumdar
- Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
| | - Rajat Mann
- Cellular Organization and Signalling, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
| | - Sweety Meel
- Cellular Organization and Signalling, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
| | - Umer Farooq
- Cellular Organization and Signalling, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
- Centre for Functional Genomics and Bio-informatics, The University of Trans-Disciplinary Health Sciences and Technology, Bangalore, India
| | - Kaivalya Walavalkar
- Cellular Organization and Signalling, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
| | - Srimonta Gayen
- Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India
| | - Anurag Kumar Singh
- Cellular Organization and Signalling, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
| | - Sridhar Hannenhalli
- Cancer Data Science Lab, National Cancer Institute, NIH, Bethesda, MD, United States of America
| | - Dimple Notani
- Cellular Organization and Signalling, National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
| |
Collapse
|
12
|
Fresco A, Jacob J, Raciti P, Ciocon D, Amin B, Mann R. Hailey-Hailey disease with acantholysis of the oral and oesophagogastric mucosa. Br J Dermatol 2019; 182:1294-1296. [PMID: 31742658 DOI: 10.1111/bjd.18720] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- A Fresco
- Department of Dermatology, Duke University Medical Center, Durham, NC, U.S.A
| | - J Jacob
- Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, NY, U.S.A
| | - P Raciti
- Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, NY, U.S.A.,Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, NY, U.S.A
| | - D Ciocon
- Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, NY, U.S.A
| | - B Amin
- Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, NY, U.S.A.,Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, NY, U.S.A
| | - R Mann
- Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine/Montefiore Medical Center, The Bronx, NY, U.S.A
| |
Collapse
|
13
|
Roach R, Mann R, Gambley CG, Chapman T, Shivas RG, Rodoni B. Genomic sequence analysis reveals diversity of Australian Xanthomonas species associated with bacterial leaf spot of tomato, capsicum and chilli. BMC Genomics 2019; 20:310. [PMID: 31014247 PMCID: PMC6480910 DOI: 10.1186/s12864-019-5600-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2018] [Accepted: 03/12/2019] [Indexed: 01/03/2023] Open
Abstract
Background The genetic diversity in Australian populations of Xanthomonas species associated with bacterial leaf spot in tomato, capsicum and chilli were compared to worldwide bacterial populations. The aim of this study was to confirm the identities of these Australian Xanthomonas species and classify them in comparison to overseas isolates. Analysis of whole genome sequence allows for the investigation of bacterial population structure, pathogenicity and gene exchange, resulting in better management strategies and biosecurity. Results Phylogenetic analysis of the core genome alignments and SNP data grouped strains in distinct clades. Patterns observed in average nucleotide identity, pan genome structure, effector and carbohydrate active enzyme profiles reflected the whole genome phylogeny and highlight taxonomic issues in X. perforans and X. euvesicatoria. Circular sequences with similarity to previously characterised plasmids were identified, and plasmids of similar sizes were isolated. Potential false positive and false negative plasmid assemblies were discussed. Effector patterns that may influence virulence on host plant species were analysed in pathogenic and non-pathogenic xanthomonads. Conclusions The phylogeny presented here confirmed X. vesicatoria, X. arboricola, X. euvesicatoria and X. perforans and a clade of an uncharacterised Xanthomonas species shown to be genetically distinct from all other strains of this study. The taxonomic status of X. perforans and X. euvesicatoria as one species is discussed in relation to whole genome phylogeny and phenotypic traits. The patterns evident in enzyme and plasmid profiles indicate worldwide exchange of genetic material with the potential to introduce new virulence elements into local bacterial populations. Electronic supplementary material The online version of this article (10.1186/s12864-019-5600-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- R Roach
- Department of Agriculture and Fisheries, Ecosciences Precinct, Brisbane, QLD, Australia. .,Agriculture Victoria Research Division, Department of Economic Development, Jobs, Transport & Resources, AgriBio, La Trobe University, Bundoora, Victoria, 3083, Australia.
| | - R Mann
- Agriculture Victoria Research Division, Department of Economic Development, Jobs, Transport & Resources, AgriBio, La Trobe University, Bundoora, Victoria, 3083, Australia
| | - C G Gambley
- Department of Agriculture and Fisheries, Applethorpe Research Facility, Applethorpe, QLD, Australia
| | - T Chapman
- Department of Primary Industries, Elizabeth Macarthur Agricultural Institute, Menangle, NSW, Australia
| | - R G Shivas
- Centre for Crop Health, University of Southern Queensland, Toowoomba, QLD, Australia
| | - B Rodoni
- Agriculture Victoria Research Division, Department of Economic Development, Jobs, Transport & Resources, AgriBio, La Trobe University, Bundoora, Victoria, 3083, Australia
| |
Collapse
|
14
|
Tilanus-Linthorst MM, Saadatmand S, Geuzinge AH, Rutgers EJ, Mann R, de Roy van Zuidewijn DB, Zonderland HM, Tollenaar RA, Lobbes MB, Ausems MG, van 't Riet M, Hooning MJ, Mares-Engelbert I, Luiten EJ, Heijnsdijk EA, Verhoef C, Karssemeijer N, Oosterwijk JC, Obdeijn IM, de Koning HJ. Abstract P6-13-01: MRI breast cancer screening compared to mammography in women with a familial risk: A multicenter randomized controlled trial. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p6-13-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Screening guidelines for women with a family history of breast cancer without a known causative gene mutation differ per country. No randomized controlled trial has been performed to assess the optimal screening strategy for these women.
Methods: In twelve centers, 1355 women aged 30–55 years with a cumulative lifetime risk of ≥20% without a BRCA1/2 mutation were randomized into two arms. From January 2011 until December 2017, women in the MRI-arm received yearly MRI-screening, clinical breast examination (CBE), and mammography every other year; and in the Mx-arm yearly mammography and CBE. Outcomes were number and stage of detected breast cancers, sensitivity, specificity and positive predictive value, and stratified by screening round and by mammographic density.
Results: After on average 4.3 screening rounds per woman, in the MRI-arm (N=675) compared to the Mx-arm (N=680) more breast cancers were detected (41 versus 14, p<0.001), invasive cancers were smaller (median size 8 versus 17 mm, p=0.006) and less often node positive (20% versus 71.4%, p=0.019)(Table). In the MRI-arm, sensitivity was slightly higher (95.1% versus 92.9%, p=1), and specificity significantly lower (82% versus 90.1%, p<0.001), compared to the Mx-arm. After two rounds, specificity improved for both modalities (87.1% for MRI; 93.0% for Mx; p<0.001) and no ≥T2 tumors or interval cancers occurred in the MRI-arm. All tumors ≥T2 were in the two highest density categories. MRI detected more small invasive tumors than Mx across all density categories.
Conclusions: In real-life practice the MRI-arm detected more, relevantly smaller, and far more often node negative tumors, and also at low density in women with a familial risk for breast cancer.
Table 1Characteristics of participating women at baseline and of the detected breast cancers, according to study armParticipantsMRI-arm n=675Mx-arm n=680MRI-arm vs. Mx-arm p-valueMean age yr ± SD44.6 ± 6.244.7 ± 6.3 Premenopausal512 (76%)505 (74%) Previous Mx ≤ 2 yr536 (79 %)542 (80%) Previous Mx > 2 years ago23 ( 3%)29 ( 4%) Previous MRI ≤ 2 years ago62 ( 9%)81 (12%) Previous MRI > 2 years ago91 (14%)89 (13%) BI-RADS density category* I (entirely fat)88 (13%)92 (14%) II (scattered densities)248 (37%)229 (34%) III (heterogeneously dense)238 (35%)243 (36%) IV (extremely dense)98 (15%)102 (15%) Mean age at cancer detection49,6 ± 7.049,8 ± 4,70.74No cancer – no. (%)634 (94%)666 (98%) Invasive breast cancers – no. (%)25 (4%)7 (1%)<0.001 (noBC/inv BC/DCIS)DCIS – no. (%)16 (2%)7 (1%) Median size of invasive cancers8 mm17 mm0.006T1a/b15 (60%)1 (14%) T1c7 (28%)4 (57%)0.078 (T1a-b/T1c/≥ T2)≥ T23 (12%)2 (29%) Node pos5 (20%)5 (71%)0.019 (N+/-)Node negative20 (80%)2 (29%) DCIS grade 15 (31%)2 (29%) DCIS grade 28 (50%)4 (57%)1 (dcis gr1,2,3)DCIS grade 33 (19%)1 (14%) *Determined by radiologists, according to the fourth ACR BI-RADS edition
Citation Format: Tilanus-Linthorst MM, Saadatmand S, Geuzinge AH, Rutgers EJ, Mann R, de Roy van Zuidewijn DB, Zonderland HM, Tollenaar RA, Lobbes MB, Ausems MG, van 't Riet M, Hooning MJ, Mares-Engelbert I, Luiten EJ, Heijnsdijk EA, Verhoef C, Karssemeijer N, Oosterwijk JC, Obdeijn I-M, de Koning HJ. MRI breast cancer screening compared to mammography in women with a familial risk: A multicenter randomized controlled trial [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P6-13-01.
Collapse
Affiliation(s)
- MM Tilanus-Linthorst
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - S Saadatmand
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - AH Geuzinge
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - EJ Rutgers
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - R Mann
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - DB de Roy van Zuidewijn
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - HM Zonderland
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - RA Tollenaar
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - MB Lobbes
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - MG Ausems
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - M van 't Riet
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - MJ Hooning
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - I Mares-Engelbert
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - EJ Luiten
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - EA Heijnsdijk
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - C Verhoef
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - N Karssemeijer
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - JC Oosterwijk
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - I-M Obdeijn
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| | - HJ de Koning
- Erasmus University Medical Centre, Rotterdam, Netherlands; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Radboud University Hospital, Nijmegen, Netherlands; Medical Centre Leeuwarden, Leeuwarden, Netherlands; Amsterdam University Medical Center, Amsterdam, Netherlands; Leiden University Medical Centre, Leiden, Netherlands; Academic Hospital, Maastricht, Maastricht, Netherlands; University Medical Centre, Utrecht, Netherlands; Reinier de Graaf Gasthuis, Delft, Netherlands; Vlietland Ziekenhuis, Schiedam, Netherlands; Amphia Ziekenhuis, Breda, Netherlands; University Medical Centre Groningen, Groningen, Netherlands
| |
Collapse
|
15
|
Abstract
Squamous cell carcinoma is the most common carcinoma in the oral cavity. Resection of these cancers often requires reconstruction. Nasolabial flaps are a robust and reliable local flap that provide a satisfactory outcome. We report two cases where an epidermoid cyst developed within the scar of the nasolabial flap and review the literature.
Collapse
Affiliation(s)
- R Mann
- University Hospitals Bristol NHS Foundation Trust , UK
| | - B Srinivasan
- University Hospital Southampton NHS Foundation Trust , UK
| | - R Webb
- University Hospital Southampton NHS Foundation Trust , UK
| | - A Webb
- University Hospital Southampton NHS Foundation Trust , UK
| |
Collapse
|
16
|
Abstract
The structure of pore spaces in typical catalyst particles could often be described as being “not so much fabricated as thrown together”. Thus whilst for certain materials, such as zeolites, the microstructures are well defined and have a precise geometry, most materials when used in typical particulate form are at least partly composed of chaotically configured pore spaces. These random pore structures can be important in determining an adsorbent's performance, so it is necessary to define them quantitatively. A heirarchy of approaches based upon developments from simple stochastic pore networks is described. A stochastic pore network is one in which simple pore segments form interconnecting networks within which pores can be either randomly or partly randomly distributed. Such stochastic networks can be characterised by mercury porosimetry and low-temperature gas adsorption. Interconnectivity and randomness affect the degree of hysteresis for both these techniques. For 3-D random pattern stochastic networks, it is possible to interpret sectioned SEM images using ‘random’ slices of particles subject to low melting point alloy visual porosimetry in order to arrive at measures of random pore structure. This ‘image analysis’ approach is being extended to 3-D image reconstruction of SEM sections using fractal surfaces in conjunction with randomly tortuous pores.
Collapse
Affiliation(s)
- R. Mann
- Department of Chemical Engineering, UMIST, Manchester, M60 1QD, UK
| | - H.N.S. Yousef
- Department of Chemical Engineering, UMIST, Manchester, M60 1QD, UK
| |
Collapse
|
17
|
|
18
|
Schaefer C, Adams E, Udall M, Masters E, Mann R, Daniel S, McElroy H, Cappelleri J, Clair A, Hopps M, Staud R, Mease P, Silverman S. THU0321 Multisite Prospective Observational Study of Fibromyalgia Patients in the Us. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
19
|
Mann R, Malisoux L, Nührenbörger C, Urhausen A, Meijer K, Theisen D. Association of previous injury and speed with running style and stride-to-stride fluctuations. Scand J Med Sci Sports 2014; 25:e638-45. [PMID: 25557130 DOI: 10.1111/sms.12397] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/22/2014] [Indexed: 11/28/2022]
Abstract
Running-related injuries remain problematic among recreational runners. We evaluated the association between having sustained a recent running-related injury and speed, and the strike index (a measure of footstrike pattern, SI) and spatiotemporal parameters of running. Forty-four previously injured and 46 previously uninjured runners underwent treadmill running at 80%, 90%, 100%, 110%, and 120% of their preferred running speed. Participants wore a pressure insole device to measure SI, temporal parameters, and stride length (S(length)) and stride frequency (S(frequency)) over 2-min intervals. Coefficient of variation and detrended fluctuation analysis provided information on stride-to-stride variability and correlative patterns. Linear mixed models were used to compare differences between groups and changes with speed. Previously injured runners displayed significantly higher stride-to-stride correlations of SI than controls (P = 0.046). As speed increased, SI, contact time (T(contact)), stride time (T(stride)), and duty factor (DF) decreased (P < 0.001), whereas flight time (T(flight)), S(length), and S(frequency) increased (P < 0.001). Stride-to-stride variability decreased significantly for SI, T(contact), T(flight), and DF (P ≤ 0.005), as did correlative patterns for T(contact), T(stride), DF, S(length), and S(frequency) (P ≤ 0.044). Previous running-related injury was associated with less stride-to-stride randomness of footstrike pattern. Overall, runners became more pronounced rearfoot strikers as running speed increased.
Collapse
Affiliation(s)
- R Mann
- Sports Medicine Research Laboratory, Public Research Centre for Health, Luxembourg, Luxembourg.,NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University, Maastricht, The Netherlands
| | - L Malisoux
- Sports Medicine Research Laboratory, Public Research Centre for Health, Luxembourg, Luxembourg
| | - C Nührenbörger
- Sports Clinic, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg
| | - A Urhausen
- Sports Medicine Research Laboratory, Public Research Centre for Health, Luxembourg, Luxembourg.,Sports Clinic, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg
| | - K Meijer
- NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University, Maastricht, The Netherlands
| | - D Theisen
- Sports Medicine Research Laboratory, Public Research Centre for Health, Luxembourg, Luxembourg
| |
Collapse
|
20
|
Samcam I, Rivera-Serrano C, Patel N, Mann R, Wong F, Werning J, Singhal D. The inferior turbinate flap: a novel technique for prosthetic preparation of a total rhinectomy defect. Int J Oral Maxillofac Surg 2014; 44:424-6. [PMID: 25533901 DOI: 10.1016/j.ijom.2014.11.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2014] [Revised: 09/23/2014] [Accepted: 11/21/2014] [Indexed: 10/24/2022]
Abstract
For total rhinectomy defects, the decision to proceed with a prosthetic versus surgical reconstruction is multifactorial, taking into account patient risk factors, availability of donor tissues, the need for tumor surveillance, and personal preferences. When a prosthetic approach is chosen, the reconstructive surgeon is tasked with preparing the defect to maximize prosthetic retention and prevent ulcerations. Stable bone coverage is critical to achieve this aim. Although skin grafting has been described previously for bone coverage, the periosteum is often stripped. We present a novel use of the inferior turbinate flap for preparation of rhinectomy defects that can be utilized regardless of the presence or absence of the periosteum and provides a more durable coverage than skin grafts.
Collapse
Affiliation(s)
- I Samcam
- Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Florida Health System, University of Florida Medical School, Gainesville, FL, USA
| | - C Rivera-Serrano
- Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Florida Health System, University of Florida Medical School, Gainesville, FL, USA
| | - N Patel
- Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Florida Health System, University of Florida Medical School, Gainesville, FL, USA
| | - R Mann
- Maxillofacial Prosthetic Services, University of Florida College of Dentistry, Gainesville, FL, USA
| | - F Wong
- Maxillofacial Prosthetic Services, University of Florida College of Dentistry, Gainesville, FL, USA
| | - J Werning
- Department of Otolaryngology, University of Florida Health System, University of Florida Medical School, Gainesville, FL, USA
| | - D Singhal
- Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Florida Health System, University of Florida Medical School, Gainesville, FL, USA.
| |
Collapse
|
21
|
Mann R, Meijer K, Malisoux L, Brunner R, Urhausen A, Nuehrenboerger C, Theisen D. FLUCTUATIONS IN STRIKE INDEX AND SPATIOTEMPORAL PARAMETERS IN PREVIOUSLY INJURED VS UNINJURED RUNNERS. Br J Sports Med 2014. [DOI: 10.1136/bjsports-2014-093494.196] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
22
|
Wilson A, Cameron D, Evans G, Broeders M, Lerda D, Knox S, Gilbert F, Skaane P, Evans A, Mann R, Bick U, Ramirez A, Michell M. E03. Update on breast cancer screening. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)70055-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
23
|
Nishio K, Ikezoe H, Hofmann S, Heßberger F, Ackermann D, Antalic S, Aritomo Y, Comas V, Düllman C, Gorshkov A, Graeger R, Heinz S, Heredia J, Hirose K, Khuyagbaatar J, Kindler B, Kojouharov I, Lommel B, Makii H, Mann R, Mitsuoka S, Nagame Y, Nishinaka I, Ohtsuki T, Popeko A, Saro S, Schädel M, Türler A, Wakabayashi Y, Watanabe Y, Yakushev A, Yeremin A. Study of heavy-ion induced fission for heavy-element synthesis. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20146603065] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
|
25
|
Malisoux L, Ramesh J, Mann R, Seil R, Urhausen A, Theisen D. Can parallel use of different running shoes decrease running-related injury risk? Scand J Med Sci Sports 2013; 25:110-5. [DOI: 10.1111/sms.12154] [Citation(s) in RCA: 50] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/22/2013] [Indexed: 11/28/2022]
Affiliation(s)
- L. Malisoux
- Sports Medicine Research Laboratory; Public Research Centre for Health; Luxembourg Grand-Duchy of Luxembourg
| | - J. Ramesh
- Sports Medicine Research Laboratory; Public Research Centre for Health; Luxembourg Grand-Duchy of Luxembourg
| | - R. Mann
- Sports Medicine Research Laboratory; Public Research Centre for Health; Luxembourg Grand-Duchy of Luxembourg
| | - R. Seil
- Sports Medicine Research Laboratory; Public Research Centre for Health; Luxembourg Grand-Duchy of Luxembourg
- Sports Clinic; Clinique d'Eich; Centre Hospitalier de Luxembourg; Luxembourg Grand-Duchy of Luxembourg
| | - A. Urhausen
- Sports Medicine Research Laboratory; Public Research Centre for Health; Luxembourg Grand-Duchy of Luxembourg
- Sports Clinic; Clinique d'Eich; Centre Hospitalier de Luxembourg; Luxembourg Grand-Duchy of Luxembourg
| | - D. Theisen
- Sports Medicine Research Laboratory; Public Research Centre for Health; Luxembourg Grand-Duchy of Luxembourg
| |
Collapse
|
26
|
Ilie G, Cusimano M, Boak A, Mann R, Adlaf E, Asbridge M, Rehm J. Incidence and mechanisms of traumatic brain injury and the relationship with psychological health among Ontario adolescents. J Neurol Sci 2013. [DOI: 10.1016/j.jns.2013.07.2143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
27
|
|
28
|
Andreyev AN, Huyse M, Van Duppen P, Qi C, Liotta RJ, Antalic S, Ackermann D, Franchoo S, Heßberger FP, Hofmann S, Kojouharov I, Kindler B, Kuusiniemi P, Lesher SR, Lommel B, Mann R, Nishio K, Page RD, Streicher B, Šáro Š, Sulignano B, Wiseman D, Wyss RA. Signatures of the Z = 82 shell closure in α-decay process. Phys Rev Lett 2013; 110:242502. [PMID: 25165917 DOI: 10.1103/physrevlett.110.242502] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2013] [Indexed: 06/03/2023]
Abstract
In recent experiments at the velocity filter Separator for Heavy Ion reaction Products (SHIP) (GSI, Darmstadt), an extended and improved set of α-decay data for more than 20 of the most neutron-deficient isotopes in the region from lead to thorium was obtained. The combined analysis of this newly available α-decay data, of which the (186)Po decay is reported here, allowed us for the first time to clearly show that crossing the Z = 82 shell to higher proton numbers strongly accelerates the α decay. From the experimental data, the α-particle formation probabilities are deduced following the Universal Decay Law approach. The formation probabilities are discussed in the framework of the pairing force acting among the protons and the neutrons forming the α particle. A striking resemblance between the phenomenological pairing gap deduced from experimental binding energies and the formation probabilities is noted. These findings support the conjecture that both the N = 126 and Z = 82 shell closures strongly influence the α-formation probability.
Collapse
Affiliation(s)
- A N Andreyev
- Instituut voor Kern- en Stralingsfysica, KU Leuven, B-3001 Leuven, Belgium and Department of Physics, University of York, York YO10 5DD, United Kingdom and Advanced Science Research Center, Japan Atomic Energy Agency (JAEA), Tokai-mura, Ibaraki 319-1195, Japan
| | - M Huyse
- Instituut voor Kern- en Stralingsfysica, KU Leuven, B-3001 Leuven, Belgium
| | - P Van Duppen
- Instituut voor Kern- en Stralingsfysica, KU Leuven, B-3001 Leuven, Belgium
| | - C Qi
- Department of Physics, Royal Institute of Technology, 10405 Stockholm, Sweden
| | - R J Liotta
- Department of Physics, Royal Institute of Technology, 10405 Stockholm, Sweden
| | - S Antalic
- Department of Nuclear Physics and Biophysics, Comenius University, 84248 Bratislava, Slovakia
| | - D Ackermann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | | | - F P Heßberger
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - S Hofmann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany and Institut für Physik, Goethe-Universität Frankfurt, 60438 Frankfurt, Germany
| | - I Kojouharov
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - B Kindler
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - P Kuusiniemi
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - S R Lesher
- Instituut voor Kern- en Stralingsfysica, KU Leuven, B-3001 Leuven, Belgium
| | - B Lommel
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - R Mann
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - K Nishio
- Advanced Science Research Center, Japan Atomic Energy Agency (JAEA), Tokai-mura, Ibaraki 319-1195, Japan
| | - R D Page
- Department of Physics, Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - B Streicher
- Department of Nuclear Physics and Biophysics, Comenius University, 84248 Bratislava, Slovakia
| | - Š Šáro
- Department of Nuclear Physics and Biophysics, Comenius University, 84248 Bratislava, Slovakia
| | - B Sulignano
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - D Wiseman
- Department of Physics, Oliver Lodge Laboratory, University of Liverpool, Liverpool L69 7ZE, United Kingdom
| | - R A Wyss
- Department of Physics, Royal Institute of Technology, 10405 Stockholm, Sweden
| |
Collapse
|
29
|
Mann R, Schaefer C, Sadosky A, Bergstrom F, Baik R, Parsons B, Nalamachu S, Stacey BR, Tuchman M, Anschel A, Nieshoff EC. Burden of spinal cord injury-related neuropathic pain in the United States: retrospective chart review and cross-sectional survey. Spinal Cord 2013; 51:564-70. [DOI: 10.1038/sc.2013.34] [Citation(s) in RCA: 66] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2012] [Revised: 02/28/2013] [Accepted: 03/16/2013] [Indexed: 11/09/2022]
|
30
|
Asbridge M, Rehm J, Mann R, Cusimano M. CANNABIS AND TRAFFIC COLLISIONS: FINDINGS FROM A CASE CROSSOVER STUDY OF PATIENTS PRESENTING TO EMERGENCY DEPARTMENTS IN TWO CANADIAN CITIES. Inj Prev 2012. [DOI: 10.1136/injuryprev-2012-040580c.30] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
31
|
Wilson A, Nyström L, Paci E, Gilbert F, Mann R. E4. Current issues in breast cancer screening. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)70055-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
32
|
Nishio K, Ikezoe H, Hofmann S, Ackermann D, Antalic S, Aritomo Y, Comas V, Düllmann C, Gorshkov A, Graeger R, Hagino K, Heinz S, Heredia J, Hirose K, Khuyagbaatar J, Kindler B, Kojouharov I, Lommel B, Makii H, Mann R, Mitsuoka S, Nagame Y, Nishinaka I, Ohtsuki T, Popeko A, Saro S, Schädel M, Türler A, Wakabayashi Y, Watanabe Y, Yakushev A, Yeremin A. Investigation of fission properties and evaporation residue measurement in the reactions using238U target nucleus. EPJ Web of Conferences 2011. [DOI: 10.1051/epjconf/20111709005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
33
|
Flechtner-Mors M, Thamm M, Rosario AS, Goldapp C, Hoffmeister U, Mann R, Bullinger M, van Egmond-Fröhlich A, Ravens-Sieberer U, Reinehr T, Westenhöfer J, Holl RW. Hypertonie, Dyslipoproteinämie und BMI-Kategorie charakterisieren das kardiovaskuläre Risiko bei übergewichtigen oder adipösen Kindern und Jugendlichen: Daten der BZgA-Beobachtungsstudie (EvAKuJ-Projekt) und der KiGGS-Studie. Klin Padiatr 2011; 223:445-9. [DOI: 10.1055/s-0031-1280766] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
34
|
Mann R, Patel S, Singh M. DLBCL awareness. Br Dent J 2011; 211:193. [PMID: 21904338 DOI: 10.1038/sj.bdj.2011.728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
35
|
Hoffmeister U, Molz E, Bullinger M, van Egmond-Fröhlich A, Goldapp C, Mann R, Ravens-Sieberer U, Reinehr T, Westenhöfer J, Wille N, Holl R. Evaluation von Therapieangeboten für adipöse Kinder und Jugendliche (EvAKuJ-Projekt). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2011; 54:603-10. [DOI: 10.1007/s00103-011-1257-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
36
|
|
37
|
Goldapp C, Cremer M, Graf C, Grünewald-Funk D, Mann R, Ungerer-Röhrich U, Willhöft C. [Quality criteria for health promotion and primary prevention measures in association with obesity in children and adolescents. A BZgA-coordinated expert consensus]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2011; 54:295-303. [PMID: 21347762 DOI: 10.1007/s00103-010-1222-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
On behalf of the Federal Ministry of Health, a working group coordinated by the Federal Center for Health Education (BZgA) compiled quality criteria for health promotion and primary prevention measures in association with obesity in children and adolescents that are applicable both to population-wide and to target group-specific measures. The criteria are intended to support the planning of new measures and the conceptual improvement of existing measures. Additional elements are the assessment of programs for financing purposes and the rendering of accounts to funding agencies, as well as the acquisition of further knowledge. The criteria, thus, address not only project developers and providers, but also multipliers who implement measures, as well as funding agencies, who can use the criteria as a basis for assessing the measures. The structure of the quality criteria is geared to the fundamental structure of the Public Health Action Cycle. In addition, resource orientation, participation and, above all, organizational development are important aspects associated with quality that have not been given adequate consideration to date. The quality criteria are applicable to all situation-based and behavioral prevention measures, and also development processes that focus on promoting the health and normal weight development of children and adolescents.
Collapse
Affiliation(s)
- C Goldapp
- Bundeszentrale für gesundheitliche Aufklärung, Ostmerheimer Strasse 22, Köln, Germany.
| | | | | | | | | | | | | |
Collapse
|
38
|
Hoffmeister U, Bullinger M, Egmond-Fröhlich AV, Goldapp C, Mann R, Ravens-Sieberer U, Reinehr T, Westenhöfer J, Holl R. Beobachtungsstudie der BZgA zur Adipositastherapie bei Kindern und Jugendlichen in Deutschland: Anthropometrie, Komorbidität und Sozialstatus. Klin Padiatr 2010; 222:274-8. [DOI: 10.1055/s-0030-1248318] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
39
|
Soni A, Irani SR, Lang B, Taghipour K, Mann R, Vincent A, Collins D. Immunotherapy: responsive autoimmune encephalopathy associated with bullous pemphigoid. J Neurol Neurosurg Psychiatry 2009; 80:1412-3. [PMID: 19917827 DOI: 10.1136/jnnp.2008.165894] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
40
|
Hewitt C, Gilbody S, Brealey S, Paulden M, Palmer S, Mann R, Green J, Morrell J, Barkham M, Light K, Richards D. Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. Health Technol Assess 2009; 13:1-145, 147-230. [PMID: 19624978 DOI: 10.3310/hta13360] [Citation(s) in RCA: 149] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
OBJECTIVES To provide an overview of methods to identify postnatal depression (PND) in primary care and to assess their validity, acceptability, clinical effectiveness and cost-effectiveness, to model estimates of cost, to assess whether any method meets UK National Screening Committee (NSC) criteria and to identify areas for future research. DATA SOURCES Searches of 20 electronic databases (including MEDLINE, CINAHL, PsycINFO, EMBASE, CENTRAL, DARE and CDSR), forward citation searching, personal communication with authors and searching of reference lists. REVIEW METHODS A generalised linear mixed model approach to the bivariate meta-analysis was undertaken for the validation review with quality assessment using QUADAS. Within the acceptability review, a textual narrative approach was employed to synthesise qualitative and quantitative research evidence. For the clinical and cost-effectiveness reviews methods outlined by the Centre for Reviews and Dissemination and the Cochrane Collaboration were followed. Probabilistic models were developed to estimate the costs associated with different identification strategies. RESULTS The Edinburgh Postnatal Depression Scale (EPDS) was the most frequently explored instrument across all of the reviews. In terms of test performance, postnatally the EPDS performed reasonably well: sensitivity ranged from 0.60 (specificity 0.97) to 0.96 (specificity 0.45) for major depression only; from 0.31 (specificity 0.99) to 0.91 (specificity 0.67) for major or minor depression; and from 0.38 (specificity 0.99) to 0.86 (specificity 0.87) for any psychiatric disorder. Evidence from the acceptability review indicated that, in the majority of studies, the EPDS was acceptable to women and health-care professionals when women were forewarned of the process, when the EPDS was administered in the home, with due attention to training, with empathetic skills of the health visitor and due consideration to positive responses to question 10 about self-harm. Suggestive evidence from the clinical effectiveness review indicated that use of the EPDS, compared with usual care, may lead to reductions in the number of women with depression scores above a threshold. In the absence of existing cost-effectiveness studies of PND identification strategies, a decision-analytic model was developed. The results of the base-case analysis suggested that use of formal identification strategies did not appear to represent value for money, based on conventional thresholds of cost-effectiveness used in the NHS. However, the scenarios considered demonstrated that this conclusion was primarily driven by the costs of false positives assumed in the base-case model. CONCLUSIONS In light of the results of our evidence synthesis and decision modelling we revisited the examination of PND screening against five of the NSC criteria. We found that the accepted criteria for a PND screening programme were not currently met. The evidence suggested that there is a simple, safe, precise and validated screening test, in principle a suitable cut-off level could be defined and that the test is acceptable to the population. Evidence surrounding clinical and cost-effectiveness of methods to identify PND is lacking. Further research should aim to identify the optimal identification strategy, in terms of key psychometric properties for postnatal populations. In particular, research comparing the performance of the Whooley and help questions, the EPDS and a generic depression measure would be informative. It would also be informative to identify the natural history of PND over time and to identify the clinical effectiveness of the most valid and acceptable method to identify postnatal depression. Further research within a randomised controlled trial would provide robust estimates of the clinical effectiveness.
Collapse
Affiliation(s)
- C Hewitt
- Department of Health Sciences, University of York, UK
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
|
42
|
Rodgers T, Stephenson D, Cooke M, York T, Mann R. Tomographic imaging during semi-batch reactive precipitation of barium sulphate in a stirred vessel. Chem Eng Res Des 2009. [DOI: 10.1016/j.cherd.2008.12.026] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
43
|
Jung J, Kita H, Mann R, Tsigrelis C, Baddour L, Jacobson R, Boyce T, Juhn Y. Assessment of the Influence of Asthma Status on Serotype-Specific Antibody Response to Pneumococcal Polysaccharide Antigens. J Allergy Clin Immunol 2009. [DOI: 10.1016/j.jaci.2008.12.286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
44
|
Carrington C, Mann R, El Jack S. An Objective Approach to Haemostasis Following Trans-radial Cardiac Catheterization. Heart Lung Circ 2009. [DOI: 10.1016/j.hlc.2009.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
45
|
Abstract
The primary cause of hypoglycaemia in Type 2 diabetes is diabetes medication-in particular, those which raise insulin levels independently of blood glucose, such as sulphonylureas (SUs) and exogenous insulin. The risk of hypoglycaemia is increased in older patients, those with longer diabetes duration, lesser insulin reserve and perhaps in the drive for strict glycaemic control. Differing definitions, data collection methods, drug type/regimen and patient populations make comparing rates of hypoglycaemia difficult. It is clear that patients taking insulin have the highest rates of self-reported severe hypoglycaemia (25% in patients who have been taking insulin for > 5 years). SUs are associated with significantly lower rates of severe hypoglycaemia. However, large numbers of patients take SUs in the UK, and it is estimated that each year > 5000 patients will experience a severe event caused by their SU therapy which will require emergency intervention. Hypoglycaemia has substantial clinical impact, in terms of mortality, morbidity and quality of life. The cost implications of severe episodes-both direct hospital costs and indirect costs-are considerable: it is estimated that each hospital admission for severe hypoglycaemia costs around pound1000. Hypoglycaemia and fear of hypoglycaemia limit the ability of current diabetes medications to achieve and maintain optimal levels of glycaemic control. Newer therapies, which focus on the incretin axis, may carry a lower risk of hypoglycaemia. Their use, and more prudent use of older therapies with low risk of hypoglycaemia, may help patients achieve improved glucose control for longer, and reduce the risk of diabetic complications.
Collapse
Affiliation(s)
- S A Amiel
- King's College London School of Medicine, London, UK
| | | | | | | |
Collapse
|
46
|
Veltman J, Mann R, Kok T, Obdeijn IM, Hoogerbrugge N, Blickman JG, Boetes C. Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI. Eur Radiol 2008; 18:931-8. [PMID: 18270717 PMCID: PMC2292493 DOI: 10.1007/s00330-008-0851-y] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2007] [Revised: 11/07/2007] [Accepted: 12/18/2007] [Indexed: 12/12/2022]
Abstract
The appearance of malignant lesions in BRCA1 and BRCA2 mutation carriers (BRCA-MCs) on mammography and magnetic resonance imaging (MRI) was evaluated. Thus, 29 BRCA-MCs with breast cancer were retrospectively evaluated and the results compared with an age, tumor size and tumor type matched control group of 29 sporadic breast cancer cases. Detection rates on both modalities were evaluated. Tumors were analyzed on morphology, density (mammography), enhancement pattern and kinetics (MRI). Overall detection was significantly better with MRI than with mammography (55/58 vs 44/57, P = 0.021). On mammography, lesions in the BRCA-MC group were significantly more described as rounded (12//19 vs 3/13, P = 0.036) and with sharp margins (9/19 vs 1/13, P = 0.024). On MRI lesions in the BRCA-MC group were significantly more described as rounded (16/27 vs 7/28, P = 0.010), with sharp margins (20/27 vs 7/28, P < 0.001) and with rim enhancement (7/27 vs 1/28, P = 0.025). No significant difference was found for enhancement kinetics (P = 0.667). Malignant lesions in BRCA-MC frequently have morphological characteristics commonly seen in benign lesions, like a rounded shape or sharp margins. This applies for both mammography and MRI. However the possibility of MRI to evaluate the enhancement pattern and kinetics enables the detection of characteristics suggestive for a malignancy.
Collapse
Affiliation(s)
- J Veltman
- 430 Department of Radiology, University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
| | | | | | | | | | | | | |
Collapse
|
47
|
MacDonald S, Mann R, Chipman M, Pakula B, Erickson P, Hathaway A, MacIntyre P. Driving behavior under the influence of cannabis or cocaine. Traffic Inj Prev 2008; 9:190-194. [PMID: 18570139 DOI: 10.1080/15389580802040295] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
OBJECTIVE The purpose of this study is first to describe perceptions of driving under the influence of cannabis or cocaine among clients in treatment and, second, to assess whether these perceptions are related to the frequency of driving under the influence of cannabis or cocaine. METHODS A questionnaire was administered to clients in treatment for abuse of either cocaine or cannabis, many of whom also had a problem with alcohol; additional groups of clients consisted of those in smoking cessation and gambling programs (N = 1021). Open-ended and close-ended questions were used to assess self-reported effects of cannabis or cocaine on driving and frequency of driving under the influence of cannabis, cocaine, or alcohol. RESULTS Two dimensions of driving behavior under the influence of cocaine or cannabis were found in both qualitative and quantitative analyses: 1) physical effects and 2) reckless styles of driving. Common physical effects for both drugs were heightened nervousness, greater alertness, and poorer concentration. In terms of driving behavior, cautious or normal driving was commonly reported for cannabis, whereas reckless or reduced driving ability was frequently reported for cocaine. When comparing negative physical effects and reckless style of driving with frequency of driving under the influence of cannabis or cocaine, increased negative physical effects from cannabis were inversely related to frequency of driving under the influence of cannabis (p = .001), but other relationships were not significant. CONCLUSIONS The findings indicate that both cannabis and cocaine have detrimental but different effects on driving. The negative physical effects of cannabis may reduce the likelihood of driving under the influence of cannabis.
Collapse
Affiliation(s)
- Scott MacDonald
- Centre for Addictions Research of British Columbia, Victoria, British Columbia, Canada
| | | | | | | | | | | | | |
Collapse
|
48
|
Mann R, Nasr N, Hadden D, Sinfield J, Abidi F, Al-Sabah S, de Maturana RL, Treece-Birch J, Willshaw A, Donnelly D. Peptide binding at the GLP-1 receptor. Biochem Soc Trans 2007; 35:713-6. [PMID: 17635131 DOI: 10.1042/bst0350713] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The receptor for GLP-1 [glucagon-like peptide-1-(7-36)-amide] is a member of the 'Family B' of GPCRs (G-protein-coupled receptors) comprising an extracellular N-terminal domain containing six conserved cysteine residues (the N-domain) and a core domain (or J-domain) comprising the seven transmembrane helices and interconnecting loop regions. According to the two-domain model for peptide binding, the N-domain is primarily responsible for providing most of the peptide binding energy, whereas the core domain is responsible for binding the N-terminal region of the peptide agonists and transmitting the signal to the intracellular G-protein. Two interesting differences between the binding properties of two GLP-1 receptor agonists, GLP-1 and EX-4 (exendin-4), can be observed. First, while GLP-1 requires its full length to maintain high affinity, the eight N-terminal residues of EX-4 can be removed with little reduction in affinity. Secondly, EX-4 (but not GLP-1) can bind to the fully isolated N-domain of the receptor with an affinity matching that of the full-length receptor. In order to better understand these differences, we have studied the interaction between combinations of full-length or truncated ligands with full-length or truncated receptors.
Collapse
Affiliation(s)
- R Mann
- Institute of Membrane and Systems Biology, LIGHT Laboratories, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
|
50
|
|